Ampicillin 8gm in Ns 400ml
Lack of sterility assurance
Yes — there is an active recall. 1 ongoing FDA recall mention Ampicillin (36 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Ampicillin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Lack of sterility assurance
Lack of sterility assurance
Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.
cGMP deviations: Temperature abuse
Presence of Particulate Matter: particulate matter identified after reconstitution.
Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients.
Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial.
Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels.
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.
Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.